Clinical outcomes for patients with schizophrenia following an acute myocardial infarction compared with patients without schizophrenia at 5 years
Unadjusted HR (95% CI) | Adjusted HR (95% CI) | |||
Model 1 | Model 2 | Model 3 | ||
MACE | 1.35 (1.23 to 1.47)* | 2.44 (2.23 to 2.67)* | 2.20 (1.79 to 2.72)* | 2.05 (1.63 to 2.58)* |
Mortality | 1.44 (1.31 to 1.59)* | 2.99 (2.72 to 3.29)* | 2.53 (1.00 to 3.21)* | 2.38 (1.84 to 3.09)* |
Reinfarction | 1.00 (0.82 to 1.24) | 1.53 (1.25 to 1.89)* | 1.41 (0.86 to 2.30) | 1.29 (0.77 to 2.13) |
Stroke | 1.03 (0.80 to 1.34) | 1.67 (1.29 to 2.17)* | 1.72 (1.00 to 2.97) | 1.72 (1.00 to 2.98) |
Heart failure | 1.25 (1.10 to 1.42)* | 2.14 (1.88 to 2.42)* | 1.49 (1.13 to 1.98)* | 1.39 (1.04 to 1.86)* |
Bleeding | 1.09 (0.86 to 1.37) | 1.55 (1.23 to 1.95)* | 1.35 (0.85 to 2.14) | 1.27 (0.79 to 2.05) |
Model 1: adjusted for age and sex.
Model 2: adjusted for age, sex, smoking, comorbidities, previous CAG and previous PCI.
Model 3: adjusted for age, sex, smoking, comorbidities, previous CAG and previous PCI, discharge medications and treatment with CAG and PCI.
*p<0.005.
CAG, coronary angiography; MACE, major adverse cardiac outcome (all-cause mortality, rehospitalisation for AMI, hospitalisation for stroke or heart failure); PCI, percutaneous coronary intervention.